Enveda Biosciences: $55 Million Closed To Use AI For Translating Nature Into New Medicines
By Amit Chowdhry ● Jun 19, 2024
Enveda Biosciences, a biotechnology company that utilizes AI to translate nature into new medicines, announced a new funding round of $55 million to add to its $119 million combined Series B and B1. The new investors, Premji Invest, Lingotto Investment Fund, Microsoft, and The Nature Conservancy, participated in the round alongside existing investors Kinnevik, True Ventures, FPV, Level Ventures, and Jazz Venture Partners.